首页> Current medical research and opinion> Evaluation of the cost-effectiveness of rifaximin-alpha for the management of patients with hepatic encephalopathy in the United Kingdom

Evaluation of the cost-effectiveness of rifaximin-alpha for the management of patients with hepatic encephalopathy in the United Kingdom

导出原文传递

翻译打印收藏纠错

作者： Berni, Ellen ^[1] ; Murphy, Daniel ^[2] ; Whitehouse, James ; Conway, Pete ; di Maggio, Paola ; Currie, Craig J. ; Poole, Chris

作者单位： Pharmatelligence, Cardiff, S Glam, Wales ^[1] Norgine Pharmaceut Ltd, Harefield, Middx, England ^[2]

关键词 Hepatic encephalopathy rifaximin cost-utility analysis cost-benefit analysis

发布时间 2019-05-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Current medical research and opinion

2018年34卷11期

2001-2008页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Current medical research and opinion

2018年34卷11期

2001-2008页

检索历史清除

Evaluation of the cost-effectiveness of rifaximin-alpha for the management of patients with hepatic encephalopathy in the United Kingdom

Current medical research and opinion

相似文献

Current medical research and opinion

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of the cost-effectiveness of rifaximin-alpha for the management of patients with hepatic encephalopathy in the United Kingdom

Current medical research and opinion

相似文献

Current medical research and opinion

相关期刊

检索历史清除